‘The Question Is, What’s Going To Happen Next?’ – The Future For Biosimilars In Europe

Isabell Remus And Julie Maréchal-Jamil Discuss Next Steps

 
• By Dave Wallace
  
The latest developments cast Europe’s biosimilars industry in a fresh light (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars & Generics

More from Agency Leadership